n-acetylserotonin has been researched along with Disease Models, Animal in 7 studies
N-acetylserotonin : An N-acylserotonin resulting from the formal condensation of the primary amino group of serotonin with the carboxy group of acetic acid.
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Melatonin and N-acetylserotonin (NAS) are tryptophan metabolites that have potent anti-oxidant, anti-inflammatory and neuroprotective properties in several animal models of neurological injury and disease including multiple sclerosis (MS)." | 7.83 | Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis. ( Ariyannur, PS; Kirmani, BF; Moffett, JR; Namboodiri, AM; Ribeiro, R; Tanaka, M; Wen, J; Zhang, Y, 2016) |
| "Melatonin and N-acetylserotonin (NAS) are tryptophan metabolites that have potent anti-oxidant, anti-inflammatory and neuroprotective properties in several animal models of neurological injury and disease including multiple sclerosis (MS)." | 3.83 | Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis. ( Ariyannur, PS; Kirmani, BF; Moffett, JR; Namboodiri, AM; Ribeiro, R; Tanaka, M; Wen, J; Zhang, Y, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Mondanelli, G | 1 |
| Coletti, A | 1 |
| Greco, FA | 1 |
| Pallotta, MT | 1 |
| Orabona, C | 1 |
| Iacono, A | 1 |
| Belladonna, ML | 1 |
| Albini, E | 1 |
| Panfili, E | 1 |
| Fallarino, F | 1 |
| Gargaro, M | 1 |
| Manni, G | 1 |
| Matino, D | 1 |
| Carvalho, A | 1 |
| Cunha, C | 1 |
| Maciel, P | 1 |
| Di Filippo, M | 1 |
| Gaetani, L | 1 |
| Bianchi, R | 1 |
| Vacca, C | 1 |
| Iamandii, IM | 1 |
| Proietti, E | 1 |
| Boscia, F | 1 |
| Annunziato, L | 1 |
| Peppelenbosch, M | 1 |
| Puccetti, P | 1 |
| Calabresi, P | 1 |
| Macchiarulo, A | 1 |
| Santambrogio, L | 1 |
| Volpi, C | 1 |
| Grohmann, U | 1 |
| Liu, J | 1 |
| Zhang, N | 1 |
| Zhang, M | 1 |
| Yin, H | 1 |
| Zhang, X | 1 |
| Wang, X | 2 |
| Zhao, Y | 1 |
| Wen, J | 1 |
| Ariyannur, PS | 1 |
| Ribeiro, R | 1 |
| Tanaka, M | 1 |
| Moffett, JR | 1 |
| Kirmani, BF | 1 |
| Namboodiri, AM | 1 |
| Zhang, Y | 1 |
| Lima, E | 1 |
| Cabral, FR | 1 |
| Cavalheiro, EA | 1 |
| Naffah-Mazzacoratti, Mda G | 1 |
| Amado, D | 1 |
| Klemm, P | 1 |
| Ostrowski, J | 1 |
| Morath, T | 1 |
| Gruber, C | 1 |
| Martorana, PA | 1 |
| Henning, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Melatonin on Seizure Outcome, Neuronal Damage and Quality of Life in Patients With Generalized Epilepsy: A Randomized, add-on Placebo-controlled Clinical Trial[NCT03590197] | Phase 4 | 104 participants (Actual) | Interventional | 2018-08-06 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
7 other studies available for n-acetylserotonin and Disease Models, Animal
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
Positive allosteric modulation of indoleamine 2,3-dioxygenase 1 restrains neuroinflammation.
Topics: Allosteric Regulation; Allosteric Site; Animals; Biocatalysis; Disease Models, Animal; Encephalomyel | 2020 |
N-acetylserotonin alleviated the expression of interleukin-1β in retinal ischemia-reperfusion rats via the TLR4/NF-κB/NLRP3 pathway.
Topics: Animals; Disease Models, Animal; Immunohistochemistry; Inflammasomes; Interleukin-18; Male; NLR Fami | 2021 |
Efficacy of N-Acetylserotonin and Melatonin in the EAE Model of Multiple Sclerosis.
Topics: Animals; Cells, Cultured; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Femal | 2016 |
Melatonin administration after pilocarpine-induced status epilepticus: a new way to prevent or attenuate postlesion epilepsy?
Topics: Analysis of Variance; Animals; Antioxidants; Cell Death; Disease Models, Animal; Hippocampus; Male; | 2011 |
N-Acetylserotonin prevents the hypotension induced by bacterial lipopolysaccharides in the rat.
Topics: Amino Acid Oxidoreductases; Animals; Blood Pressure; Disease Models, Animal; Hypotension; Lipopolysa | 1993 |